Our researchers are currently in need of adult and pediatric study participants to help us pursue better treatments and cures. Participants may receive medical evaluations and procedures, study medication, disease-related education and possible financial compensation for time, travel and participation.
The purpose of this study is to measure and accurately identify the presence and severity of gastroesphageal reflux disease (GERD), commonly called acid reflux, in idiopathic pulmonary fibrosis (IPF) patients using the Supraglottic Index (SGI).
The purpose of this study is to investigate inherited genetic factors that play a role in the development of familial pulmonary fibrosis and to identify a group of genes that predispose individuals to develop pulmonary fibrosis.
With some autoimmune conditions, interstitial lung disease (ILD) can be a complication that worsens breathing and makes it harder for people to live normally. Researchers are investigating a new medication that may be able to help slow lung fibrosis in autoimmune-related ILD cases. Volunteers are needed
Researchers in the WISPer study are evaluating if an investigational treatment for IPF is safe and helps improve symptoms. Volunteers with IPF are needed.
The purpose of this study is to measure and accurately identify the presence and severity of gastroesphageal reflux disease (GERD), commonly called acid reflux, in idiopathic pulmonary fibrosis (IPF) patients using the Supraglottic Index (SGI).
The purpose of this study is to investigate inherited genetic factors that play a role in the development of familial pulmonary fibrosis and to identify a group of genes that predispose individuals to develop pulmonary fibrosis.
With some autoimmune conditions, interstitial lung disease (ILD) can be a complication that worsens breathing and makes it harder for people to live normally. Researchers are investigating a new medication that may be able to help slow lung fibrosis in autoimmune-related ILD cases. Volunteers are needed
Researchers in the WISPer study are evaluating if an investigational treatment for IPF is safe and helps improve symptoms. Volunteers with IPF are needed.
With some autoimmune conditions, interstitial lung disease (ILD) can be a complication that worsens breathing and makes it harder for people to live normally. Researchers are investigating a new medication that may be able to help slow lung fibrosis in autoimmune-related ILD cases. Volunteers are needed
